Skip to main content
Genomic Vision logo

Genomic Vision — Investor Relations & Filings

Ticker · GV ISIN · FR0011799907 LEI · 969500UXJNBY1C8Y8471 PA Professional, scientific and technical activities
Open in API
Filings indexed 412 across all filing types
Latest filing 2015-02-17 Regulatory Filings
Country FR France
Listing PA GV

About Genomic Vision

https://www.genomicvision.com/

Genomic Vision is a biotechnology company specializing in the direct visualization and analysis of single DNA molecules through its proprietary Molecular Combing technology. This platform provides highly accurate characterization of large-scale genomic modifications, offering critical insights into genetic integrity and stability. The company's primary focus is on providing quality control (QC) solutions for the bioproduction and cell and gene therapy markets, ensuring the safety and efficacy of advanced therapeutic products. In drug discovery, its Replication Combing Assay (RCA) is used to assess the effects of compounds on DNA replication. Genomic Vision's tools and services support the entire lifecycle of biopharmaceutical development, from research to production.

Recent filings

Filing Released Lang Actions
Communicated under the obligation to provide permanent information / Activity of the issuer (acquisition, sale, partnerships, etc.)
Regulatory Filings Classification · 95% confidence The document is explicitly titled as a "Press release" and details a strategic collaboration renewal and amendment between Genomic Vision and Quest Diagnostics, including changes to marketing rights and royalty rates. This type of announcement, which communicates a significant business development or partnership update, does not fit the specific definitions for financial reports (10-K, IR, ER), shareholder actions (AGM-R, DVA), or management changes (MANG). It is a general corporate announcement regarding business operations and strategic agreements. Since it is not a standard regulatory filing like a 10-K or a specific financial report, and it details a significant business event, it falls best under the general category of Regulatory Filings (RNS) as a catch-all for important, non-standard announcements, although it is clearly a press release. Given the options, RNS is the most appropriate fallback for a significant corporate press release that isn't a defined financial report or specific corporate action.
2015-02-17 English
Communiqués au titre de l'obligation d'information permanente / Activité de l'émetteur (acquisitions, cessions, partenariats, …)
Legal Proceedings Report Classification · 99% confidence The document is a press release announcing the renewal and extension of a strategic collaboration between Genomic Vision and Quest Diagnostics, detailing changes in partnership terms, royalties, and future opportunities. It is not a formal regulatory filing like a 10-K, an official Audit Report (AR), or a detailed Interim Report (IR). It is an announcement concerning business operations, partnerships, and financial terms (royalties). This type of announcement, which details strategic business developments rather than specific financial results (ER) or management changes (MANG), often falls under general Regulatory Filings (RNS) or, given its focus on business strategy and partnership value, could be considered a general corporate update. Since it is a press release announcing a significant business event and not a specific financial report, and it doesn't fit perfectly into the other specific categories (like DIV, CAP, or M&A), RNS (Regulatory Filings/General Announcement) is the most appropriate fallback. However, because it heavily discusses the commercialization and expansion of diagnostic tests and the financial terms associated with them, it is a significant corporate announcement. Given the options, RNS serves as the best general category for non-standard, material press releases.
2015-02-17 French
Communicated under the obligation to provide permanent information / Other communications
Report Publication Announcement Classification · 99% confidence The document is titled '2015 Financial Agenda' and explicitly states that the company 'publishes its financial agenda for 2015,' listing future dates for key financial events like '2014 Full-Year Results,' 'Q1 2015 Revenue,' and 'Shareholders' Meeting.' This is a press release announcing a schedule of future corporate events, not the actual financial report (like 10-K or IR) or the transcript of a call. Since it is an announcement regarding the timing and schedule of future reports/meetings, it best fits the 'Report Publication Announcement' (RPA) category, which covers announcements about the release of other reports, or potentially a general Regulatory Filing (RNS). Given the specific nature of announcing a schedule of financial report releases, RPA is the most precise fit.
2015-02-09 English
Communiqués au titre de l'obligation d'information permanente / Autres communiqués
Report Publication Announcement Classification · 99% confidence The document is titled "Agenda financier 2015" and explicitly lists future dates for key corporate events such as 'Résultats annuels 2014' (Annual Results), 'Chiffre d'affaires du 1er trimestre 2015' (Q1 Revenue), and 'Assemblée générale' (General Meeting). This content is a forward-looking schedule of financial and corporate events, not the actual release of results (ER), a full report (10-K/IR), or a presentation (IP). It is an announcement detailing when future reports or meetings will occur. Since it is an announcement about the timing of future corporate events, it best fits the category for announcing the publication of reports, which is Report Publication Announcement (RPA). Although it mentions the AGM date, the primary purpose is the entire financial calendar, making RPA more appropriate than AGM-R.
2015-02-09 French
Communicated under the obligation to provide permanent information / Communication relating to accounts, results, and turnover
Earnings Release Classification · 98% confidence The document explicitly announces 'revenue from sales and cash position at December 31, 2014'. It presents key financial figures for Q4 2014 and the full year 2014, including revenue tables and cash balances. This content structure—a summary of financial performance for a specific period (annual in this case) released before the full audited report—is characteristic of an Earnings Release (ER). It is not the comprehensive 10-K, nor is it a transcript (CT) or a management discussion (MDA), although it contains some commentary. The document also mentions the '2014 full-year results, on April 30, 2015', indicating this release is the preliminary announcement of those results. FY 2014
2015-01-15 English
Communiqués au titre de l'obligation d'information permanente / Communiqué sur comptes, résultats, chiffres d’affaires
Earnings Release Classification · 98% confidence The document is a press release announcing the company's financial results for the full year 2014 (Chiffre d'affaires annuel 2014) and the 4th quarter, including key figures for revenue and cash position as of December 31, 2014. It explicitly states that the results are 'non auditées' (unaudited) and points to a future date for the 'Résultats annuels 2014' (Annual results 2014). This structure—a brief announcement highlighting key performance indicators for a period, often preceding a more detailed filing or a formal earnings release—is characteristic of an Earnings Release (ER). It is not the comprehensive Annual Report (10-K) nor the formal Audit Report (AR). Since it provides the initial summary of period results, ER is the most appropriate classification. FY 2014
2015-01-15 French

Browse filings by year

10 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.